Board of Directors

Barry Uphoff – Capricorn Investment Group

Barry Uphoff is a Partner with Capricorn Investment Group. At Capricorn, Barry leads the investment team with a particular focus on healthcare and wellness investing. Prior to joining Capricorn, Barry was a senior investment professional at Silver Point Capital, a Greenwich, Connecticut-based hedge fund with approximately $7 billion in total assets under management. Barry earned his BA from the Johns Hopkins University with highest honors and Phi Beta Kappa distinction and read for a Diploma in Law and an MSc in Medicine at Oxford University under the auspices of a Rhodes Scholarship. He received an MBA from the University of Chicago, Graduate School of Business with highest honors.

Phil Young – US Venture Partners

Phil Young is a Venture Partner with US Venture Partners. Prior to joining USVP in 1990, Phil spent four years with Concord Partners, Dillon Read’s venture capital operation in Palo Alto. With a specialty in the medical device industry, Phil has watched the evolution of new methodologies, such as the emergence of minimally-invasive treatments, into increasingly diverse and pervasive applications. Before moving into venture capital he was President and CEO of Oximetrix, a manufacturer of critical care instruments and disposables, where he spent eight years growing the privately held venture-backed company from $1 million in revenues to nearly $50 million. Oximetrix was acquired by Abbott Laboratories and became Abbott Critical Care.

Casey Tansey – US Venture Partners

Casey Tansey joined USVP as a general partner in April 2005. A veteran of the medical device industry, Casey brings over 25 years of entrepreneurial, early-stage medical device and seasoned operating experience to USVP. During his tenure as CEO and President of Epicor Medical from 2001 to 2004, Casey, along with a dedicated team, pioneered a minimally-invasive treatment for atrial fibrillation and transformed the company into a recognized market leader. He led Epicor’s acquisition by St. Jude Medical at a valuation of more than $200 million. Prior to Epicor, Casey was CEO and President of Heartport, a public company that helped pioneer minimally-invasive cardiac surgery which is now a Johnson & Johnson company. Before that, he was with Baxter Edward’s Cardiovascular Division for nearly ten years, holding various sales and marketing positions. During his tenure at Baxter, Casey was involved in launching innovative heart valve products that have grown to be the market leaders.

Lonnie M. Smith – Chairman of the Board, Intuitive Surgical

Lonnie Smith joined Intuitive Surgical as President and CEO in June 1997, and currently serves as Chairman of the Board of Directors. During his tenure as CEO, Intuitive Surgical grew from a start-up with no revenue to over one billion dollars in revenue and approximately 1,300 employees. Prior to joining Intuitive Surgical, Mr. Smith was Senior Executive Vice President of Hillenbrand Industries. Mr. Smith joined Hillenbrand in 1978; during his tenure, he was a member of the executive committee, the office of the president and the board of directors. Mr. Smith has also held positions at The Boston Consulting Group and IBM. Mr. Smith receives his B.S.E.E. from Utah State University and an M.B.A. from Harvard Business School.